Health Care & Life Sciences » Pharmaceuticals | Nemus Bioscience Inc.

Nemus Bioscience Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
52.20
207.30
3,258.70
102.30
264.40
Total Accounts Receivable
38.40
-
-
-
-
Other Current Assets
15.60
101.10
195.10
177.20
291.40
Total Current Assets
106.10
308.40
3,453.80
279.50
555.80
Net Property, Plant & Equipment
39.60
21.40
13.40
9.60
1.40
Other Assets
-
18.60
43.90
34.30
-
Total Assets
145.70
348.30
3,511.00
323.40
557.20
ST Debt & Current Portion LT Debt
47.20
-
-
-
235.00
Accounts Payable
15.10
-
-
-
100.90
Income Tax Payable
-
0.80
-
-
-
Other Current Liabilities
0.00
800.30
581.90
662.00
470.10
Total Current Liabilities
62.30
801.10
581.90
662.00
806.00
Other Liabilities
-
0.80
2,458.20
1,112.30
551.30
Total Liabilities
62.30
801.90
3,040.10
1,774.30
1,357.30
Common Equity (Total)
83.40
453.50
892.20
2,914.20
3,569.50
Total Shareholders' Equity
83.40
453.50
471.00
1,450.90
800.10
Total Equity
83.40
453.50
471.00
1,450.90
800.10
Liabilities & Shareholders' Equity
145.70
348.30
3,511.00
323.40
557.20
Preferred Stock (Carrying Value)
-
-
1,363.20
1,463.30
2,769.40

About Nemus Bioscience

View Profile
Address
600 Anton Boulevard
Costa Mesa California 92626
United States
Employees -
Website http://www.nemusbioscience.com
Updated 09/14/2018
Nemus Bioscience, Inc. is a biopharmaceutical company. It is focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids, designed to alleviate a variety of diseases and symptoms by selectively targeting CB1 and CB2 receptors. The company was founded on October 31, 2014 and is headquartered in Costa Mesa, CA.